2015 American Transplant Congress

May 2-6, 2015 in Philadelphia, Pennsylvania

View by Title View Sessions

View by Date

Tuesday, May 5, 2015

5:30pm-6:30pm: Chemokine Receptor 5 Blockade Modulates Inflammation and Immunity in Renal Ischemic Reperfusion Injury

K. Yoo,¹ S. Han,¹ J. Park,¹ E. Bae,¹ J. Park,¹ J. An,¹ J. Lee,¹ D. Kim,¹ Y. Kim,^1,2 S. Yang.²

Poster Session D: Innate Immunity in Transplantation • Exhibit Hall E

5:30pm-6:30pm: Chest Wall,Thymus, and Heart Transplant: Pushing the Boundary of Solid Organ Allotransplantation

G. Torregrossa,¹ M. Sosin,² G. Gerosa,³ A. Dorafshar.²

Poster Session D: Late Breaking • Exhibit Hall E

5:30pm-6:30pm: Clinical Course of Pre-Existing Monoclonal Gammopathies Following Kidney Transplant

C. Johnson.

Poster Session D: PTLD/Malignancies: All Topics • Exhibit Hall E

5:30pm-6:30pm: Clinical Impact of 18F-FDG-PET/CT in Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma

S. Lee, S. Kim.

Poster Session D: Liver Transplantation for Hepatocellular Carcinoma • Exhibit Hall E

5:30pm-6:30pm: Clinical Use of Gene-Expression Profiling to Monitor for Rejection After Cardiac Transplantation – Which Patients and When?

J. Teuteberg,¹ M. Shullo,¹ T. Wolf,² P. Prasad,² G. Ewald.³

Poster Session D: "The Tell-Tale Heart": Allograft Rejection and Post-Transplant Monitoring • Exhibit Hall E

5:30pm-6:30pm: Clusterin-Regulated Transcriptome in the Kidney During Ischemia-Reperfusion

G. Dairi, Q. Guan, A. Haegert, C. Collins, M. Gleave, C. Nguan, C. Du.

Poster Session D: Innate Immunity in Transplantation • Exhibit Hall E

5:30pm-6:30pm: CMV IgG Provides Similar Anti-CMV Efficacy as Valganciclovir in High-Risk Organ Transplant Recipients, With Reduced Costs

N. Pilch, D. Taber, C. Schaffner, S. Nadig, J. McGillicuddy, C. Bratton, P. Baliga, K. Chavin.

Poster Session D: Viral Infections • Exhibit Hall E

5:30pm-6:30pm: Comparative Survival Benefits and Costs of an Eplet and Broad Antigen Based Matching System in Deceased Donor Kidney Transplant Allocation Among Indigenous Australians

H. Do Nguyen,¹ G. Wong,^2,3 J. Chapman,² J. Craig,^2,3 L. D'Orsogna,⁴ W. Lim.^1,5

Poster Session D: Immunology, Biomarkers and Immunosuppression • Exhibit Hall E

5:30pm-6:30pm: Comparison of Efficacy and Renal Function in KidneyTransplant Recipients Receiving Tacrolimus (TAC)-Based Immunosuppressive Regimens in Combination With Everolimus (EVR) or Mycophenolate (MPA)

A. Ferreira,¹ C. Felipe,¹ P. Ueno,¹ P. Hannun,¹ P. Ruppel,¹ T. Sandes-Freitas,¹ H. Proença,³ J. Medina- Pestana,¹ H. Tedesco-Silva.¹

Poster Session D: Kidney Immunosuppression: Drug Minimization • Exhibit Hall E

5:30pm-6:30pm: Comprehensive Study of 3 Nomenclatures to Discriminate CD8 Subsets in Healthy Volunteers and in Kidney Transplant Recipients

M. Yap,^1,3 G. Tilly,^1,3 M. Giral,^1,2 S. Brouard,^1,2 N. Degauque.^1,2

Poster Session D: Costimulation and Signaling in Lymphocytes • Exhibit Hall E